AU2002217414A1 - Skin-protective compositions effective against vesicants and percutaneous chemical agents - Google Patents
Skin-protective compositions effective against vesicants and percutaneous chemical agentsInfo
- Publication number
- AU2002217414A1 AU2002217414A1 AU2002217414A AU2002217414A AU2002217414A1 AU 2002217414 A1 AU2002217414 A1 AU 2002217414A1 AU 2002217414 A AU2002217414 A AU 2002217414A AU 2002217414 A AU2002217414 A AU 2002217414A AU 2002217414 A1 AU2002217414 A1 AU 2002217414A1
- Authority
- AU
- Australia
- Prior art keywords
- protective agent
- agent according
- acid
- protective
- ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013043 chemical agent Substances 0.000 title claims description 10
- 239000000203 mixture Substances 0.000 title description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 34
- 239000006071 cream Substances 0.000 claims description 34
- 239000003223 protective agent Substances 0.000 claims description 25
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 22
- 239000000654 additive Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 17
- 230000001681 protective effect Effects 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 230000000996 additive effect Effects 0.000 claims description 11
- -1 ethane dithiophosphate ion Chemical class 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- 150000002772 monosaccharides Chemical class 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 230000006378 damage Effects 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 150000002482 oligosaccharides Polymers 0.000 claims description 6
- 229920005862 polyol Polymers 0.000 claims description 6
- 150000003077 polyols Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 208000014674 injury Diseases 0.000 claims description 5
- 150000002500 ions Chemical class 0.000 claims description 5
- 230000003902 lesion Effects 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical class OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical class NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical class OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical class OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- SPSSULHKWOKEEL-UHFFFAOYSA-N 2,4,6-trinitrotoluene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O SPSSULHKWOKEEL-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Chemical class 0.000 claims description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical class OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 claims description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Chemical class OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical class OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000004471 Glycine Chemical class 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical class SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical class OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical class C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical class OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Chemical class NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Chemical class 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical class OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical class OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Chemical class 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Chemical class OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Chemical class SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000000174 gluconic acid Chemical class 0.000 claims description 2
- 235000012208 gluconic acid Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 239000004310 lactic acid Chemical class 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 235000018977 lysine Nutrition 0.000 claims description 2
- PIOZZBNFRIZETM-UHFFFAOYSA-L magnesium;2-carbonoperoxoylbenzoic acid;2-oxidooxycarbonylbenzoate Chemical compound [Mg+2].OOC(=O)C1=CC=CC=C1C([O-])=O.OOC(=O)C1=CC=CC=C1C([O-])=O PIOZZBNFRIZETM-UHFFFAOYSA-L 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002978 peroxides Chemical class 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- AVTYONGGKAJVTE-UHFFFAOYSA-L potassium tartrate Chemical compound [K+].[K+].[O-]C(=O)C(O)C(O)C([O-])=O AVTYONGGKAJVTE-UHFFFAOYSA-L 0.000 claims description 2
- 235000013930 proline Nutrition 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- 235000004400 serine Nutrition 0.000 claims description 2
- 229940045872 sodium percarbonate Drugs 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000011975 tartaric acid Chemical class 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 3
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Chemical class OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 claims 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical class OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 claims 1
- 101100476484 Mus musculus S100a9 gene Proteins 0.000 claims 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims 1
- 230000035987 intoxication Effects 0.000 claims 1
- 231100000566 intoxication Toxicity 0.000 claims 1
- 239000004224 potassium gluconate Substances 0.000 claims 1
- 229960003189 potassium gluconate Drugs 0.000 claims 1
- 235000013926 potassium gluconate Nutrition 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 24
- 238000002360 preparation method Methods 0.000 description 12
- 241000282887 Suidae Species 0.000 description 8
- 230000004224 protection Effects 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 239000011252 protective cream Substances 0.000 description 6
- 102000012440 Acetylcholinesterase Human genes 0.000 description 4
- 108010022752 Acetylcholinesterase Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229940022698 acetylcholinesterase Drugs 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 241000219198 Brassica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BMLMGCPTLHPWPY-REOHCLBHSA-N (4R)-2-oxo-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSC(=O)N1 BMLMGCPTLHPWPY-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003463 adsorbent Chemical class 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002575 chemical warfare agent Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- PBKSAWGZZXKEBJ-UHFFFAOYSA-N cyclopenta-1,3-diene;4-cyclopenta-2,4-dien-1-ylphenol;iron(2+) Chemical compound [Fe+2].C=1C=C[CH-]C=1.C1=CC(O)=CC=C1[C-]1C=CC=C1 PBKSAWGZZXKEBJ-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000036576 dermal application Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 229960004961 mechlorethamine Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003562 morphometric effect Effects 0.000 description 1
- 238000013425 morphometry Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical class [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Description
-i-
HIGH EFFICACY PROTECTIVE COMPOSITIONS AGAINST
VESICANTS AND PERCUTANEOUS CHEMICAL AGENTS
Field of the Invention
The invention relates to protective compositions for protecting the skin
against damages caused by sulfur mustard gas and other chemical agents,
such as VX, pesticides, nitrogen mustard and poison ivy.
Background of the Invention
Sulfur mustard (both in gaseous and liquid form) is a potent cutaneous
vesicant which rapidly penetrates tl. Askin and causes prolonged injuries,
and is therefore representative of the percutaneous agents to the
protection against which the present invention is directed. Sulfur
CH2 CH2 CI
S
\ CH2 CH2 CI
(I) mustard, as an example of major hazards consists of
β-chloro-diethylsulfide of the formula:
which may further contain other components, such as other active
compounds.
VX as an example for nerve agent: 0-ethyl-S-(2-diisopropylaminoethyl-
methylphosphothiolate), of the formula:
O
I , 0CH2CH3
CH3 — p
^ S CH2 CH2N (CH (CH3)2) )2
There are two main ways known in the art of protecting a person's skin
against chemical warfare agents such as mustard: The first method is a
passive protection which involves covering the skin with a protective
cover, such as a protective cloth. This method has several drawbacks:
firstly, the protective clothings are heavy and uncomfortable to wear for a
long period of time, and therefore they cannot be continuously worn as a
preventive measure. Secondly, the protective covers leave areas
unprotected, such as the hands and neck, and therefore do not offer
complete protection. Furthermore, such protective measures are quite
expensive, which of course limits their usefulness.
The second method involves applying reactive materials to the skin, which
react with the sulfur mustard gas and neutralize it. The drawback
associated with this method is that it requires to apply to the skin active
materials which generally are in themselves harmful, typically require the
application of oily and uncomfortable materials to the skin, and
furthermore are as yet only limited in efficacy. Additionally, such reactive
materials are also generally required in large amounts, which are difficult
to apply to the skin.
Other protections, which involve the use of creams which promote the
creation of a polymeric film on the skin are also not very effective, since
the film cracks and leaves areas below the cracks exposed. Furthermore,
such films are thick and uncomfortable to the user. Another cream exists,
which penetrates the skin, leaving an outer layer that can act as a matrix
for active protecting agents. This cream also exhibits the drawbacks
described above. In addition, this protective cream requires a thick layer
to be applied. The above composition may be toxic to the respiratory
system due to fumes emerging from smoking products, such as cigarettes,
and thus it is not effective in hot environments or where fire is present.
The art, notwithstanding the many efforts devoted to the solution of this
problem, has failed so far to provide a solution to the above problem, viz.,
a protection for the skin which overcomes the above drawbacks.
It is therefore an object of this invention to provide a protective agent
which is effective against sulfur mustard and other chemical agents, such
as VX, and which overcomes the drawbacks of prior art protections.
It is another purpose of this invention to provide a protective agent which
can be applied to the skin often, which does not lead to discomfort, and
which is not harmful to the skin.
It is yet another purpose of the invention to provide a protective agent
which remains effective for a long period of time after application, in the
order of 6 - 12 hours before exposure to the harmful chemical agent.
Other purposes and advantages of this invention will appear as the
description proceeds.
Summary of the Invention
The invention is directed to a protective agent suitable to protect the
human skin against sulfur mustard gas injury, nerve agents such as VX
and injury from other harmful chemical agents, comprising a
protective-effective amount of a hydrophilic water-based cream, alone or
together with one or more additives selected from among the group
consisting essentially of polyols, mono-, oligo- or polysaccharides, salts of
organic or inorganic acids, and absorbant compounds.
The term "cream", as used herein, is intended to indicate any preparation
of sufficient viscosity to remain on the skin for a sufficient period of time
so as to be absorbed into its surface, and' should be understood to include
also preparations of appearance other than creamy, such as lotions or
ointments.
According to a preferred embodiment of the invention the additive polyol
is selected from among polyethylene glycol, propylene glycol, polyglycerol,
glycerin, sorbitol, dulcitol, tritol, sorbitol or mannitol.
According to another preferred embodiment of the invention the additive
monosaccharide is selected from among arabinose, ribose, xylose, glucose,
fructose, galactose and mannose.
According to still another preferred embodiment of the invention the
synergistic additive oligosaccharide is selected from among sucrose,
maltose, lactose, raffinose or cellobiose.
According to yet another preferred embodiment of the invention the
additive polysaccharide is selected from among starch or gum arabicum.
The protective agent may contain, according to another preferred
embodiment of the invention, an additive salt selected from among salts of
citric acid, glycolic acid, gluconic acid, tartaric acid, glucaric acid, glyceric
acid, lactic acid, ascorbic acid, thioglycolic acid, benzoic acid, acetic acid,
glycine, alanine, serine, lysine, aspartic acid, cysteine, proline, glutamic
acid, δ-hydroxyl sine, glutamine or urea.
The hydrophihc water -based cream of the invention may be of different
types, the important requirements from such base cream being its
hydrophihc nature, and its ability to be spread on the skin and accepted
thereby. For this purpose, glycerin is particularly suitable, since it is
absorbed into the skin and interacts with the epidermis, to provide a
homogeneous and long-lasting protective layer which effectively protects
the skin against sulfur mustard, VX and other chemical insults, even in
the absence of additives.
Without wishing to be bound by any particular theory, it is the inventor's
belief that the action of the cream of the invention is due to its hydrophihc
behavior, which repels sulfur mustard from the skin surface. The addition
of hydrophihc additives of the kind employed in this invention, further
enhance this phenomenon and creates a "salting-out-like" effect toward
the sulfur mustard and other chemical agents. Thus, for instance, the
addition of salts to the cream displaces water molecules and caused a
repulsion of the sulfur mustard or other toxic organic agents away from
the skin.
While, as stated, glycerin is the preferred base for the protective agent
cream, other bases can be used. Cream is defined for the present invention
as a composition having viscosity significantly higher than water. For
example, the viscosity of glycerin is 1490-629 centipoise between 20-30°C,
respectively, sorbitol viscosity 110 centipoise at 25°C, while water viscosity
is 1.8 centipoise at 25°C. According to a preferred embodiment of the
invention the hydrophihc water-based cream contains one or more
additives, and the water-based cream consists essentially of a material
selected from among monosaccharides such as sorbitol, potassium
gluconate, potassium tartarate, potassium citrate, calcium chloride or
potassium carbonate. As stated, and as will be further detailed
hereinafter, the cream may contain additional salts, such as MgS04 or
other organic salts, or inorganic salts such as aluminum salts, MgC or
CaCl2, provided that no reaction or precipitation takes place between
them, or surface active agents such as Triton X100, esters of sugars and
lecithin.
While the presence of active materials is not a necessity in the protective
agents of the invention, any suitable active agent can be added. For
instance, the protective agent of the invention may further comprise
antiseptic materials. Furthermore, the protective agent may further
comprise reactive materials, such as nucleophilic materials, e.g.,
thiosulphate, or adsorbent compounds such as bentonite, silica gel,
zeolites. Illustrative and non -limitative examples of reactive materials
include, e.g., dithiophosphate ion, ethanedithiophosphate ion,
hexanedithiophosphate ion, butyldithiophosphate ion,
ethyldithiophosphate ion, pentaethylenedithiocarbamate, thiosulphate ion
and dialkylthiophosphate.
Additional reactive agents that may be added to the protective cream are
oxidizing materials. Unstable materials, such as H2O2, may be added on
the spot and may be provided separately from the protective cream. Other
oxidizing agents may be included in the protective cream. Illustrative and
non-limitative examples of oxidizing agents are: perchlorides, peroxides,
sodium percarbonate, H2O2: urea complex, H2O2: PVP
(polyvinylpyrrolidone) complex and magnesium monoperoxy phthalate.
Non-reactive agents may include, for instance, thickening agents such as
methylcellulose, xanthan, carboxy methyl cellulose (CMC), etc.
In another aspect, therefore, the mvention is directed to a method for
protecting the human skin against percutaneous chemical agents such as
sulfur mustard, comprising applying to the skin a protective-effective
amount of a hydrophihc water-based cream, alone or together with one or
more additives selected from among the group consisting essentially of
polyols, mono-, oligo- or polysaccharides, and salts of organic or inorganic
acids.
Brief Description of the Drawings
- Fig. 1 is a graphical description of the results obtained in Example 2.
Detailed Description of Preferred Embodiments
The above and other characteristics and advantages of the invention will
be better understood through the following illustrative and non-limitative
examples of preferred embodiments thereof.
General Procedures
Protective creams were tested for efficacy against sulfur mustard lesions
and VX poisoning. The protective potential was tested either against 0.2
and 1 microliter droplets of sulfur mustard applied topically on the back of
pigs' skin, or sulfur mustard vapor or VX (0.2 and 1 microliters). The
extent of cutaneous lesion following liquid sulfur mustard was evaluated
quantitatively using a morphometric and densitometric method with the
aid of an image analyzer.
The area of the damaged skin was measured at 24 hours post exposure
and the protective value of each cream was calculated as a percent of
control of sulfur mustard lesion (0% protection representing identity to the
sulfur mustard lesion). The same test was carried out under sweating
conditions in pigs, and gave almost identical results. When tested against
VX poisoning in pigs, the leathality and clinical signs were monitored and
the percent inhibition of acetylcholinesterase (AChE) activity was
measured in blood samples. All the pigs pretreated with the protective
creams survived a 1-5 hours challenge with lethal concentrations (twice
the LD50) of VX and did not exhibit any clinical signs, up to three hours
exposure challenges. In comparison, in the absence of the protective
cream, all animals had severe clinical symptoms and the majority died
within 24-48 hours after exposure to VX. AChE activity was significantly
higher in all animals pretreated with the cream, compared to unprotected
animals. However, some decline in blood AChE activity, induced by
dermal application of VX (1.3 g/Kg, lμl) in pigs was measured in the
treated animals (see Example 2 and Fig.l). The protective creams
provided a significant protection, even when applied 12 hours (single
application) prior to a one hour challenge with Iμl droplets of VX (2 LD50),
or sulfur mustard, when LD50 = 0.65 mg/Kg in pigs, for VX.
Five formulations were tested for irritation in controlled laboratory
studies, and were found to be non-irritating by the Draize procedure in
guinea pigs and rabbits. Three preparations were tested also in Phase I
clinical study, with young male healthy volunteers. The creams were
applied on about 20% of the skin surface. The preparations were found to
be non-irritating and safe for human use.
Preparation A
A cream composition containing potassium citrate was prepared using the
following components:
Citric acid monohydrate, 99% (ex Aldrich) 10.5 gr
KOH, 86% (ex Fluka) 8.4 gr
Distilled water 5.0 gr
Glycerin 87% (ex Merck) 20.0 gr
Comparable results were obtained when Glycerin 100% was used.
Preparation B
A cream composition containing potassium acetate was prepared using the
following components:
Potassium acetate (ex Hopkin & Williams) 30.0 gr
Glycerin 87% (ex Merck) 20.0 gr
Preparation C
A cream composition containing sorbitol was prepared using the following
components:
Sorbitol (ex BDH) 30.0 gr
Distilled water 9.0gr
Glycerin 87% (ex Merck) 15.0 gr
Preparation D
A cream composition containing potassium β-alanine was prepared using
the following components:
β-alanine, 98% (ex Aldrich) 8.9gr
KOH, 86% (ex Fluka) 5.6 gr
Distilled water 5.0gr
Glycerin 87% (ex Merck) 10.0 gr
Preparation E
A cream composition containing magnesium sulfate was prepared using
the following components:
Magnesium sulfate 10.0 gr
Glycerin 87% (ex Merck) 30.0 gr
Preparation F
A cream composition containing potassium borate was prepared using the
following components:
Sodium borate (Na2B θ7-10H2O) 20.0 gr
Glycerin 87% (ex Merck) 30.0 gr
Preparation G
A cream composition containing glycerin was prepared containing only
glycerin 87%.
Preparation H
Magnesium sulfate -7H20 1.5gr
Glycerin 87% 4.5gr
Silica gel 2 gr
Manoxol OT (dioctyl ester of sodium sulfusuccinic acid) 30 mg
Alternative surface active agents
Manoxol OT
Triton x 100
Lecithine
Sodium Lauryl Sulfate
Alternative Adsorb ants
Bentonite
Fumed silica gel
Silica gel
Nanosize- MgO, ZnO, Al203, Ti02
Zeolites
Activated charcoal
Example 1
The efficacy of various protective compositions of the invention were
tested according to the general procedure described above. The results are
summarized in Table I below:
Table I
Time of exposure to liquid sulfur mustard
** Time of application of protective agent prior to exposure
Ratio cream component:water:glycerin a NaOH b R-oxothiazolidine-4-carboxylate
Example 2
The efficacy of preparation E against VX challenge (twice the LD50, LDso=
0.65 mg/Kg in pigs) was tested in pigs according to the procedure
described above. The results of one of the experiments, where the cream of
preparation E was dermally applied once, 6 hours before a one hour
challenge with 1.3 mg/Kg VX (lμl) are shown in Fig.l.
While embodiments of the invention have been described by way of
illustration, it will be understood that the invention can be carried out by
persons skilled in the art with many modifications, variations and
adaptations, without departing from its spirit or exceeding the scope of the
claims.
Claims (18)
1. A protective agent suitable to protect the human skin against lesions
caused by vesicants or other percutaneous chemical agents, particularly
against sulfur mustard gas injury and VX intoxication, comprising a
protective-effective amount of a hydrophihc water-based cream, alone or
together with one or more additives selected from among the group
consisting essentially of polyols, mono-, oligo- or polysaccharides, and salts
of organic or inorganic acids.
2. A protective agent according to claim 1, wherein the additive polyol is
selected from among polyethylene glycol, propylene glycol, polyglygcerol,
glycerin, sorbitol, dulcitol, tritol, sorbitol or mannitol.
3. A protective agent according to claim 1, wherein the additive
monosaccharide is selected from among arabinose, ribose, xylose, glucose,
fructose, galactose, mannose.
4. A protective agent according to claim 1, wherein the additive
oligosaccharide is selected from among sucrose, maltose, lactose, raffinose
or cellobiose.
5. A protective agent according to claim 1, wherein the additive
polysaccharide is selected from among starch or gum arabicum.
6. A protective agent according to claim 1, wherein the additive salt is
selected from among salts of citric acid, glycolic acid, gluconic acid, tartaric
acid, glucaric acid, glyceric acid, lactic acid, ascorbic acid, thioglycolic acid,
benzoic acid, acetic acid, glycine, alanine, serine, lysine, aspartic acid,
cysteine, proline, glutstoic acid, 8-hydroxylysine or glutamine.
7. A protective agent according to claim 1, wherein the additive salt is
selected from among aluminum salts, MgC or CaGb.
8. A protective agent according to any one of claims 1 to 7, wherein the
hydrophylic water -based cream consists essentially of glycerin.
9. A protective agent according to any one of claims 1 to 7, wherein the
hydrophylic water-based cream contains one or more additives, and
wherein the water-based cream consists essentially of a material selected
from among monosaccharides, potassium gluconate, potassium tartarate,
potassium citrate, calcium chloride or aluminum sulfate.
10. A protective agent according to any one of claims 1 to 9, further
comprising antiseptic materials.
11. A protective agent according to any one of claims 1 to 10, further comprising reactive materials.
12. A protective agent according to claim 11, wherein the reactive material
is a nucleophylic material.
13. A protective agent according to claim 11, wherein the reactive material
is selected from among dithiophosphate ion, ethane dithiophosphate ion,
hexane, dithiophosphate ion, butyl dithiophosphate ion,
ethyldithiophosphate ion, pentaethylenedithiocarbamate, thiosulphate ion
and alkyl dithiophosphate.
14. A protective agent according to claim 11, wherein the reactive material
is an oxidizing agent.
15. A protective agent according to claim 14, wherein the oxidizing agent
is selected from among H2O2, perchlorides, peroxides, sodium
percarbonate, H2O2: urea complex, H2O2: PVP complex and magnesium
monoperoxy phthalate.
16. A method for protecting the human skin against injury caused by
vesicants or other percutaneous chemical agents, comprising applying to
the skin a protective-effective amount of a hydrophylic water-based cream,
alone or together with one or more additives selected from among the group consisting essentially of polyols, mono-, oligo- or polysaccharides,
and salts of organic or inorganic acids.
17. A method according to claim 16, wherein the vesicant is sulfur
mustard gas.
18. A method according to claim 16, wherein the organophosphate is VX.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL142812 | 2001-04-25 | ||
IL142812A IL142812A (en) | 2001-04-25 | 2001-04-25 | High efficacy protective compositions against vesicants and percutaneous chemical agents |
PCT/IL2001/001222 WO2002085322A1 (en) | 2001-04-25 | 2001-12-31 | Skin-protective compositions effective against vesicants and percutaneous chemical agents |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002217414A1 true AU2002217414A1 (en) | 2003-04-17 |
AU2002217414B2 AU2002217414B2 (en) | 2008-01-17 |
Family
ID=11075349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002217414A Ceased AU2002217414B2 (en) | 2001-04-25 | 2001-12-31 | Skin-protective compositions effective against vesicants and percutaneous chemical agents |
Country Status (9)
Country | Link |
---|---|
US (1) | US7618616B2 (en) |
EP (1) | EP1381348B1 (en) |
JP (1) | JP3874729B2 (en) |
KR (1) | KR100853443B1 (en) |
AT (1) | ATE520388T1 (en) |
AU (1) | AU2002217414B2 (en) |
CA (1) | CA2444870C (en) |
IL (1) | IL142812A (en) |
WO (1) | WO2002085322A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7592002B2 (en) * | 2005-10-31 | 2009-09-22 | Bioderm Research | Sugar esters for depilation (hair removal), demabrasion, and wrinkles reduction |
GB2411833A (en) * | 2004-03-08 | 2005-09-14 | Skin Salveation Ltd | Composition for use in the treatment of dry skin conditions |
US7527784B2 (en) * | 2005-08-31 | 2009-05-05 | Bioderm Research | Water washable hair removal (depilatory) compositions |
US8037550B2 (en) * | 2008-02-01 | 2011-10-18 | Gore Enterprise Holdings, Inc. | Stretchable chemical protective material |
CN110305036B (en) * | 2019-01-15 | 2020-09-04 | 江南大学 | Hydrogen peroxide-responsive nitrogen mustard antitumor prodrug and preparation method thereof |
KR102455140B1 (en) | 2022-03-29 | 2022-10-17 | 국방과학연구소 | Reactive skin protection composition that protects against penetration of liquid chemical agents or harmful toxic substances into the skin |
KR102551067B1 (en) | 2023-03-29 | 2023-07-04 | 국방과학연구소 | Cleaning composition for reactive skin protecting agent defending against chemical agents and cleaning method using the same |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE470954C (en) | 1924-10-24 | 1929-01-31 | Gruenau Landshoff Chem Fab | Process for the preparation of an agent suitable for subcutaneous and intravenous injections from lecithin and glycerine |
US4107330A (en) * | 1969-04-04 | 1978-08-15 | Aaron Leonard Sheffner | Topical application of thioglycolic acid in the treatment of acne |
US4259318A (en) * | 1978-03-02 | 1981-03-31 | University Of Houston, Central Campus | Poison ivy relief composition |
US4465663A (en) * | 1981-07-27 | 1984-08-14 | Basf Wyandotte Corporation | Polyoxybutylene-polyoxyethylene aqueous gels |
DE3500972A1 (en) * | 1985-01-14 | 1986-07-17 | Henkel Kgaa | SEBOSUPPRESSIVE COSMETIC AGENTS, CONTAINING ALKOXY OR ALKYLBENZYLOXY BENZOESAEUREN OR THEIR SALTS |
GB2237739B (en) * | 1985-03-22 | 1991-10-30 | Secr Defence Brit | Protective composition |
CH672066A5 (en) * | 1987-02-20 | 1989-10-31 | Modima Sa | |
US4850729A (en) * | 1987-04-07 | 1989-07-25 | David N. Kramer | Decontaminating composition and delivery system therefor |
CA1273576A (en) * | 1987-09-16 | 1990-09-04 | Patrick A. Beauchamp | Topical treatment for diseased skin disorders |
US5162378A (en) * | 1990-04-20 | 1992-11-10 | Revlon Consumer Products Corporation | Silicone containing water-in-oil microemulsions having increased salt content |
EP0545002A1 (en) * | 1991-11-21 | 1993-06-09 | Kose Corporation | Silicone polymer, paste-like composition and water-in-oil type cosmetic composition comprising the same |
US5221533A (en) * | 1992-01-31 | 1993-06-22 | Perlman H Harris | Skin lotion composition |
FR2689021B1 (en) * | 1992-03-26 | 1995-09-29 | France Etat Armement | PROCESS FOR DECONTAMINATION OF SUBSTRATE CONTAMINATED BY TOXIC AGENTS USING A PERSULFATE COMPOSITION. |
JPH06279265A (en) | 1993-03-29 | 1994-10-04 | Shiseido Co Ltd | Transparent gel composition |
US5414079A (en) * | 1993-08-03 | 1995-05-09 | Biocontrol Incorporated | Oxidized cellulose |
US5512278A (en) * | 1994-01-11 | 1996-04-30 | Phylomed Corporation | Ointment base useful for pharmaceutical preparations |
DE19528394A1 (en) * | 1994-08-13 | 1996-02-15 | Bluecher Hasso Von | Removal of chemical warfare agents from skin and materials |
US5702709A (en) * | 1995-04-18 | 1997-12-30 | Enviroderm Pharmaceuticals, Inc. | Skin allergen and irritant barrier lotion |
US5607979A (en) * | 1995-05-30 | 1997-03-04 | The United States Of America As Represented By The Secretary Of The Army | Topical skin protectants |
EP0842164A4 (en) * | 1995-07-07 | 1998-10-07 | Durham Pharmaceuticals Llc | Cyclic amides and derivatives thereof |
US5837266A (en) * | 1996-04-30 | 1998-11-17 | Hydromer, Inc. | Composition, barrier film, and method for preventing contact dermatitis |
US6224885B1 (en) * | 1996-05-17 | 2001-05-01 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Barrier cream comprising hexamethylenetetramine or derivative thereof |
WO1999049841A1 (en) | 1998-03-30 | 1999-10-07 | The Procter & Gamble Company | Skin care compositions |
ITMI991464A1 (en) * | 1999-07-02 | 2001-01-02 | Intercos Italiana | SOLID COSMETIC PRODUCT IN NONIONIC WATER-IN-OIL EMULSION |
GB9917040D0 (en) | 1999-07-21 | 1999-09-22 | Clarke Paul D | Antiseptic composition |
FR2817761B1 (en) * | 2000-12-12 | 2003-03-14 | Irfaq | DECONTAMINANT FORMULATION FOR DECONTAMINATION OF THICKENED TOXIC AGENTS |
-
2001
- 2001-04-25 IL IL142812A patent/IL142812A/en not_active IP Right Cessation
- 2001-12-31 WO PCT/IL2001/001222 patent/WO2002085322A1/en active Application Filing
- 2001-12-31 KR KR1020037013502A patent/KR100853443B1/en not_active IP Right Cessation
- 2001-12-31 AU AU2002217414A patent/AU2002217414B2/en not_active Ceased
- 2001-12-31 JP JP2002582897A patent/JP3874729B2/en not_active Expired - Fee Related
- 2001-12-31 US US10/475,878 patent/US7618616B2/en not_active Expired - Fee Related
- 2001-12-31 CA CA2444870A patent/CA2444870C/en not_active Expired - Fee Related
- 2001-12-31 EP EP01274158A patent/EP1381348B1/en not_active Expired - Lifetime
- 2001-12-31 AT AT01274158T patent/ATE520388T1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5753637A (en) | Method of treating acne conditions | |
BR9910168A (en) | Antiperspirant compositions containing 1,2 - hexanediol | |
WO2001085159A1 (en) | Topical anti-acne composition | |
US5910312A (en) | Acne treatment composition with vasoconstrictor | |
US5916574A (en) | Method of treating natural poison skin conditions | |
CA2444870C (en) | Skin-protective compositions effective against vesicants and percutaneous chemical agents | |
CA2265993A1 (en) | Novel antimicrobial cosmetic compositions | |
AU2002217414A1 (en) | Skin-protective compositions effective against vesicants and percutaneous chemical agents | |
US5702709A (en) | Skin allergen and irritant barrier lotion | |
US4404198A (en) | Phenyl Salicylate as a topical anti-inflammatory | |
EP1319387B1 (en) | Cosmetic compositions of powder-type containing whitening ingredient | |
KR20080060924A (en) | Low-irritative powder composition for washing | |
JPS627A (en) | Skin external agent containing incorporated urea | |
EP1736207A1 (en) | Depilatory composition | |
EP3226827B1 (en) | Aluminium-free antiperspirant/deodorant compositions and method of preparing the same | |
DE2456639A1 (en) | Sprayable ester contg deodorant compsn - prevents container corrosion without reducing bacteriostatic activity | |
JPH07138139A (en) | Composition for oral cavity application | |
JP4137020B2 (en) | Cosmetics | |
JP3333428B2 (en) | External preparation for skin | |
RU2164403C1 (en) | Protective-and-prophylactic cream | |
US6436415B2 (en) | Herbal deodorant | |
CA1166958A (en) | Poison ivy prevention | |
JPH0226603B2 (en) | ||
KR19990008898A (en) | Hypoallergenic cosmetic composition containing alpha hydroxy acid | |
MXPA98001210A (en) | Barrier lotion against allergens and irritants for the p |